Intellia Therapeutics Inc (NTLA)

NASDAQ HEALTHCARE
$12.45 -5.72% RSI 41 Neutral Add Alert

Moving Averages

SMA 200
$12.89
Price below

Company Profile

Intellia Therapeutics, Inc., a genome editing company, is focused on developing therapies. The company is headquartered in Cambridge, Massachusetts.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$1.59B
P/E Ratio
None
EPS
$-3.81
Beta
1.992
Dividend Yield
0.00%
52-Week High
$28.25
52-Week Low
$6.73

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 54.0
VRTX
Vertex Pharmaceuticals Inc
RSI 37.0
CRSP
CRISPR Therapeutics AG
RSI 46.0
MRNA
Moderna Inc
RSI 35.0
VKTX
Viking Therapeutics Inc
RSI 39.0
SRPT
Sarepta Therapeutics Inc
RSI 50.0

Data last updated: April 11, 2026 at 10:07 AM EDT

Track NTLA for free

Get e-mail RSI alerts when Intellia Therapeutics Inc enters oversold or overbought territory. Free forever.

Add Alert